TRYVIO 12.5 mg/1
Aprocitentan · TABLET, FILM COATED · Idorsia Pharmaceuticals Ltd
Tryvio (aprocitentan) is a prescription tablet used to treat resistant hypertension in adults whose blood pressure remains high despite other blood pressure medications. It works by blocking endothelin receptors, which helps relax blood vessels and lower blood pressure.
Key Facts
- Brand Name
- TRYVIO
- Generic Name
- Aprocitentan
- NDC Code (Product)
80491-8012- Manufacturer
- Idorsia Pharmaceuticals Ltd
- Strength
- 12.5 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA217686
- Drug Class
- Endothelin Receptor Antagonist [EPC]
- Marketing Start
- 03/20/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is TRYVIO used for?
Tryvio (aprocitentan) is a prescription tablet used to treat resistant hypertension in adults whose blood pressure remains high despite other blood pressure medications. It works by blocking endothelin receptors, which helps relax blood vessels and lower blood pressure.
Is TRYVIO a controlled substance?
TRYVIO is not classified as a controlled substance by the DEA.
What is the generic name for TRYVIO?
The generic name for TRYVIO is Aprocitentan. There are no other listed brand versions of Aprocitentan.
What is the NDC code for TRYVIO 12.5 mg/1?
The NDC (National Drug Code) for TRYVIO 12.5 mg/1 is 80491-8012, listed by Idorsia Pharmaceuticals Ltd.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)